Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: Pete Ryley who wrote (1031)	12/2/1997 12:45:00 PM
From: Mr. Miller	Respond to of 8359

Welcome Pete. You have chosen a good company. No litigation pending that I know of, and growing at a rapid rate. I had a post a while back that described my viewpoint in more detail, but I see 24 for this reason: P/E (for 12 months coming of eps .25)around June 1 of this year before conferences was around 32-36. Let us say 32 for argument. FY 1999 is expecting at least .75 and I believe Piper is raising to .85 or was talking about it. Let us work with .75. 32 X eps of .75 would be 24 by June 1. Wait a minute. I think I goofed a little. I am looking for beginning of FY1999, so that should be JULY 1st. My bust! Anyway, you see what I am getting at. Noone is saying 24 but me. It is only an opinion, and if ABTX can stay on its torrid pace of acquisitions and have over $400 million, perhaps $500 million, in total unrealized revenues, then ABTX will continue to NYSE and sponsorship by major brokerage house. Again, only my opinion. There is no guarantee that ABTX will acquire anything else, but they have a strong track record. Holding this puppy throughout "Acquisition Program" and maybe beyond depending on what ABTX can develop from a biotech viewpoint, or overseas. Excellent stock performance thus far(though we have stagnated a bit here-at least we have not dropped significantly, except for that one bad in October when we hit 6 3/4 for about 2 seconds). Right now, I don't find too much negative. They are there, but not glaring(high debt, stock dilution from acquisitions, and stagnated price). Growth activity and established management are sure fire winners for this company thus far. Miller